top of page

Testimonials

9/17/20

Video Interview

Discipline:

Life Sciences, Medicine

Giuliano Testa

Professor

Professor

Bio:

Giuliano Testa is a graduate of the University of Padova Medical School in Italy. He completed General Surgery Residencies both at the University of Padova and at the University of Chicago and then a fellowship in Abdominal Organ Transplantation at Baylor University Medical Center in Dallas, Texas.  He has been affiliated with the University of Essen, Germany, and the University of Illinois at Chicago. In 2005, he moved to the University of Chicago as Director of Liver Transplant and Hepatobiliary Surgery and rose to the rank of Professor of Surgery. In 2008, Giuliano Testa completed the Fellowship in Clinical Ethics at the MacLean Center for Clinical Ethics of the University of Chicago and joined the Faculty to become the Associate Director of the Surgical Ethics Program. In 2011 he obtained a Master's Degree in Business Administration at the University of Chicago Booth School of Business.
Giuliano Testa joined Baylor University Medical Center in July 2011 to lead the Living Donor Liver Program. In 2017 he was promoted to Division Chief and in 2019 Chairman of the Simmons Transplant Institute.

Giuliano Testa is actively involved with the American Society of Transplant Surgeons(currently member of the Living Donation Committee) and the United Network for Organ Sharing (currently member of the Ethics Committee). He is also a member of the Ethics Committee at Baylor University Medical Center.

Giuliano Testa is author or co-author of more than 160 manuscripts and several book chapters. He is a recognized authority in the field of Living Donor Liver Transplantation, Living Donor Intestinal Transplantation and Uterus Transplantation.

Webinar:

The newest treatment for Infertility: Uterus Transplantation


In 2014 a healthy child was born from a mother who had undergone a Uterus Transplant. The mother was affected by Absolute Uterine Infertility, a condition characterized by thecongenital, been born without, or acquired, having lost after birth, absence of the Uterus. Worldwide 3-5% of the women in gestational age suffer from this form of infertility. For women affected by Absolute Uterine Infertility the other only chances of having a family were adoption and surrogacy. Uterus Transplant is a unique solution for these women infertility since it is the only one that allows these women to live the experience of pregnancy and delivery.

Uterus Transplant is a unique form of transplantation since it is not used to cure an acute or chronic organ dysfunction like any other organ transplant and consequently to save or prolong life, but to restore the possibility of carrying pregnancy. Interestingly, Uterus Transplant is also the only temporary Transplant, since the uterus is removed once the birth or births occur. The recipient of a Uterus transplant must take immunosuppressive medications until the uterus is removed. A Uterus Transplant can be performed with a living or a deceased donor. To date, more than 60 UTx procedures have been reported, with at least 18 live births. Despite its success and the high number of women affected by Absolute Uterine Infertility, the true demand for Uterus Transplant is difficult to assess, in view of the cost of the procedure.

This Webinar is dedicated to the successful development of Uterus Transplant, and describes its technical development, its results, the implications it has for the women who successfully delivered their child and the ethical debate surrounding it.


To watch the video, click here.

bottom of page